Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.4.1 has been added, replacing the previous v3.4.0. This is a minor update that does not change study details or visible content.
    Difference
    0.0%
    Check dated 2026-02-06T09:10:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A new bibliographic citation about Lebrikizumab in atopic dermatitis was added to the Publications section. A nearly identical citation was removed, resulting in a small bibliographic update.
    Difference
    0.0%
    Check dated 2026-01-29T21:27:42.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The changes are minor UI/metadata edits, including glossary toggle labels (Show glossary, Hide glossary) and wording/capitalization updates (Last Update Submitted that Met QC Criteria vs met QC Criteria, No FEAR Act Data, and Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-22T17:59:07.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision tag changed from Revision: v3.3.3 to Revision: v3.3.4, indicating a minor site update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:44:00.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a new publication reference to the Publications section: 'Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities' (Ann Allergy Asthma Immunol, 2025). The DOI is 10.1016/j.anai.2025.12.017.
    Difference
    0.0%
    Check dated 2026-01-01T03:18:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The Study Details page updated its Locations list with many new sites across the US, Australia, Canada, and Europe, and removed several existing locations.
    Difference
    2%
    Check dated 2025-12-17T19:53:39.000Z thumbnail image

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.